Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors

Published:2016-05-01 Issue:3 Volume:31 Page:552-559
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Yu Ji Hyun,Kim Kyoung Woon,Kim Bo-Mi,Chung Byung Ha,Cho Mi-La,Choi Bum Soon,Park Cheol Whee,Kim Yong-Soo,Yang Chul Woo

Funder

Ministry for Health and Welfare, Republic of Korea

Publisher

Korean Association of Internal Medicine

Link

http://kjim.org/upload/kjim-2014-366.pdf

Reference21 articles.

1. The pathogenesis and treatment of chronic allograft nephropathy

2. Cancer after Kidney Transplantation in the United States

3. Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

4. Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients

5. The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-melanoma skin cancer outcomes in kidney transplant recipients converted from calcineurin inhibitors to mTOR inhibitors: a systematic review;Advances in Dermatology and Allergology;2023

2. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review;Ophthalmic Plastic & Reconstructive Surgery;2020-05

3. Biglycan evokes autophagy in macrophages via a novel CD44/Toll-like receptor 4 signaling axis in ischemia/reperfusion injury;Kidney International;2019-03

4. Regulatory B cells and advances in transplantation;Journal of Leukocyte Biology;2018-12-13

5. Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review;Lymphatic Research and Biology;2018-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3